Welcome to our dedicated page for Balchem SEC filings (Ticker: BCPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Balchem Corporation (NASDAQ: BCPC) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a global specialty ingredient manufacturer. This SEC filings page aggregates those disclosures, including current reports on Form 8-K and, via EDGAR, the company’s annual reports on Form 10-K, quarterly reports on Form 10-Q and other required filings.
Recent Form 8-K filings show how Balchem uses current reports to furnish quarterly financial results. For example, the company has filed 8-Ks under Item 2.02, “Results of Operations and Financial Condition,” to attach press releases reporting net sales, segment earnings, adjusted EBITDA and free cash flow for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments. Another Form 8-K details the results of Balchem’s annual meeting of shareholders, including director elections, auditor ratification and advisory votes on executive compensation.
Through this page, users can access Balchem’s periodic reports, which typically include segment information, risk disclosures, accounting policies and other data relevant to its specialty ingredients, animal nutrition and specialty chemical activities. Filings related to governance matters, such as shareholder voting outcomes, are also available.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, highlight key segment trends and clarify items such as non-GAAP measures referenced in Balchem’s earnings releases. Real-time updates from EDGAR help users see new 10-K, 10-Q and 8-K filings as they are posted, while Form 4 and other ownership-related filings can be reviewed to monitor insider transactions. This combination of official documents and AI-assisted analysis allows investors and researchers to study Balchem’s regulatory history, financial reporting and governance practices in a structured and accessible way.
Balchem Corp. (BCPC) EVP, Chief Legal Officer & Secretary Hatsuki Miyata filed a Form 4 reporting an internal share withholding associated with restricted-stock vesting.
- Transaction: On 07/25/2025, 483 common shares were automatically withheld (code “F”) to satisfy tax obligations at a reported price of $148.82, representing roughly $72 k of tax value.
- Post-transaction ownership: 6,189 shares held directly; 462 shares held indirectly through the company 401(k) plan.
- Interpretation: Code F is a non-discretionary event; no open-market buying or selling occurred, so investment signal is neutral.
No derivative securities were involved and there is no impact on Balchem’s capital structure.
Balchem Corporation held its Annual Meeting of Shareholders on June 18, 2025, where three significant matters were put to vote:
- Board Elections: Three Class 1 directors were elected to serve until 2028: - Theodore L. Harris (24.9M votes for) - Monica Vicente (26.4M votes for) - Matthew Wineinger (26.1M votes for)
- Auditor Appointment: Shareholders strongly approved RSM US LLP as the independent registered public accounting firm for FY2025, with 28.8 million votes in favor (98.2% approval)
- Executive Compensation: The say-on-pay vote passed with 25.4 million votes in favor (93.6% of votes cast), showing strong shareholder support for the company's executive compensation practices
All proposals received substantial shareholder approval, indicating strong governance alignment and shareholder satisfaction with the company's direction.